• "I am truly impressed with the responsiveness and help that I have obtained from genOway. It has been a pleasure to work..."

    > read full testimonial

    Prof. Bellur S. PRABHAKAR

    Associate Dean at University of Illinois College of Medicine

  • "We were highly impressed by the expert manner in which genOway’s scientists managed what I felt to be a rather..."

    > read full testimonial

    Prof. Simon C. ROBSON

    Director at Beth Israel Deaconess Medical Center

  • "genOway is the Mercedes Benz of transgenic outsourcing companies."

    > read full testimonial

    Prof. Robert TERKELTAUB

    Director at UC San Diego School of Medicine

  • "We have worked with genOway in different projects for several years, and we are very impressed by their competence,..."

    > read full testimonial

    Prof. Maria T. DIAZ-MECO

    Lab Head at Sanford Burnham Prebys Medical Discovery Institute

  • "With the idea to develop a mouse model for the rare human disease ALD, we reached out to genOway to help us in finding..."

    > read full testimonial

    Dr. Stephan KEMP

    Associate Professor at Academic Medical Center (AMC)

  • "genOway has really impressed me with the quality of its service and its competence. I would emphasize their reliability..."

    > read full testimonial

    Prof. Ruben PIO

    Director at CIMA, University of Navarra

  • "genOway has already supplied us with several difficult-to-make knockout cell lines. We are impressed by the speed and..."

    > read full testimonial

    Prof. Hans CLEVERS

    Director Research of Princess Maxima Center

  • "genOway provides us with a very professional services within the expected timelines and high quality scientific..."

    > read full testimonial

    Prof. Gerd WALZ

    Director at Albert Ludwigs University Freiburg

  • "For more than two years we have worked with the scientific staff at genOway appreciating their fruitful and constant..."

    > read full testimonial

    Prof. Gianfranco SEBASTIO

    University of Naples Federico II

  • "Mouse knock-out technology is an important step in cancer research, it provides relevant answers to scientific questions..."

    > read full testimonial

    Dr. Luisa LANFRANCONE

    IFOM-IEO Campus, University of Milan

  • "IEO and genOway collaboration started some years ago while we were looking for collaborative and highly professional..."

    > read full testimonial

    Prof. Pier Giuseppe PELICCI

    Scientific Director of the European Institute of Oncology Milan

  • "genOway has carried out several projects for us. This collaboration has been very successful. Not just because we have..."

    > read full testimonial

    Prof. Arne KLUNGLAND

    Lab Head at Oslo University Hospital

  • "I ascertain that genOway has provided extremely efficient and competent services to us and we will very likely use them..."

    > read full testimonial

    Prof. Ludwig NEYSES

    Chair of Medicine at University of Manchester

  • "genOway's technology is excellent and their mouse business is impressive. We are looking forward to working..."

    > read full testimonial

    Dr. Ulrich THIBAUT

    Supervisory Board of Glycotope GmbH Berlin

  • "Leader for the development of transgenic mice and rats, genOway is a very reliable biotechnology company. Their main..."

    > read full testimonial

    Prof. Shomi BHATTACHARYA

    Director of Cabimer

  • "genOway has a professional attitude toward its customers. We had really appreciated their innovative technologies and..."

    > read full testimonial

    Prof. Ivan DIKIC

    Director at Goethe University Frankfurt am Main

  • "I have never witnessed such proactive behavior with customers. genOway truly understand our challenges and is equipped..."

    > read full testimonial

    Dr. Carla BOCCACCIO

    University of Torino Medical School

  • "We are actively engaged in the production of a number of knock-in mouse models with genOway. We have been very pleased..."

    > read full testimonial

    Prof. Stephen MOSS

    Chair of Biomedical Research at University College London

  • "genOway has not only successful provided this service, but we have benefited a great deal from their consultation,..."

    > read full testimonial

    Dr. Paul RILEY

    Chair of Development and Cell Biology at Oxford University

  • "genOway is a leading company in the field of genetically modified mouse and rat models. Its technology platform is..."

    > read full testimonial

    Prof. Pier Paolo DI FIORE

    IFOM-IEO Campus, University of Milan

More

What We Stand For

What We Stand For

"Thorough project assessment, in-depth scientific analysis of your current and future needs, exhaustive technology portfolio, excellence in production, and dedicated customer care are the core pillars that distinguish our personalized genome engineering service...
We translate your project into the most adapted and physiologically relevant research model."

Alexandre Fraichard
General Manager - genOway

At a Glance

At a Glance

genOway has created more than 1500 genetically modified models, while serving clients in:

• 28 countries worldwide,
• 265 academic institutions and 13 EU projects,
• 70 biopharmaceutical, and
• 14 of the Top 20 pharma companies

Cell Models (Customized)

Genetically engineering of cell lines, primary and pluripotent stem cells (e.g. iPS cells).

> Read more Cell Models (Customized)

Mouse Models (Customized)

Fully adapted to your needs, ranging from basic research to preclinical studies.

> Read more Mouse Models  (Customized)

Rat Models (Customized)

Generation of Knockout and point mutation rat models on a large choice of genetic backgrounds.

> Read more Rat Models (Customized)

Mouse Lines (Catalog)

Access to the largest repository of Knockout and reporter mouse models.

> Search your target Mouse Lines (Catalog)

Phenotyping

Molecular validation of your model (gene expression, RNA stability, alternative splicing, etc.)

> Read more Phenotyping

Free Consulting

Contact our scientific consultants for a free project assessment and scientific analysis.

> Contact us Free Consulting

Latest Clients Publications

  • Lee SM et al.

    J Steroid Biochem Mol Biol. 2017...

    | The impact of VDR expression and regulation in...

    Read
  • Hu LR et al.

    Sci Adv. 2017 Jun 7

    | Deregulated Ca2+ cycling underlies the development...

    Read
  • Becker LA et al.

    Nature. 2017 Apr 20

    | Therapeutic reduction of ataxin-2 extends lifespan...

    Read
  • Zhang Z et al.

    Proc Natl Acad Sci U S A. 2017...

    | Transcription factor Etv5 is essential for the...

    Read
  • Morley BJ et al.

    J Comp Neurol. 2017 Apr 1

    | Nicotinic acetylcholine receptors regulate...

    Read